HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders.

Getz, G S; Wool, G D; Reardon, C A

Getz, G S; Wool, G D; Reardon, C A.

Affiliation

Getz GS; The University of Chicago, Department of Pathology, 5841 S. Maryland Avenue, Chicago, IL 60637, USA. g-getz@uchicago.edu

Curr Pharm Des ; 16(28): 3173-84, 2010.

Article in En | MEDLINE | ID: mdl-20687877

Subject(s)

Apolipoproteins/physiology; Atherosclerosis/drug therapy; Inflammation/drug therapy; Lipoproteins, HDL/drug effects; Peptides/therapeutic use; Animals; Anti-Inflammatory Agents/therapeutic use; Apolipoproteins/chemistry; Atherosclerosis/physiopathology; Cholesterol/metabolism; Clusterin/chemistry; Clusterin/physiology; Humans; Inflammation/physiopathology; Molecular Mimicry; Peptides/chemistry; Peptides/pharmacology; Protein Structure, Secondary

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins / Peptides / Atherosclerosis / Inflammation / Lipoproteins, HDL Limits: Animals / Humans Language: En Journal: Curr Pharm Des Journal subject: FARMACIA Year: 2010 Document type: Article Affiliation country: United States Country of publication: United Arab Emirates

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google